Harvey Capital Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q1
Sell
-35,100
Closed -$163K 89
2017
Q4
$163K Buy
+35,100
New +$163K 0.06% 81
2014
Q3
Sell
-932,400
Closed -$14.3M 76
2014
Q2
$14.3M Buy
932,400
+16,600
+2% +$255K 5.13% 2
2014
Q1
$15.6M Buy
915,800
+25,300
+3% +$431K 6.22% 1
2013
Q4
$11.5M Buy
890,500
+70,500
+9% +$913K 4.76% 6
2013
Q3
$8.27M Buy
+820,000
New +$8.27M 4.2% 8